Clinical characteristics and responses of patients with relapsed or refractory high-grade B-Cell lymphoma treated with loncastuximab tesirine in the lotis-2 clinical trial
Alderuccio, J. P. Ai, W. Z. Radford, John A Solh, M. Ardeshna, K. M. Lunning, M. A. Hess, B. T. Zinzani, P. L. Stathis, A. Carlo-Stella, C.
Alderuccio, J. P.
Ai, W. Z.
Radford, John A
Solh, M.
Ardeshna, K. M.
Lunning, M. A.
Hess, B. T.
Zinzani, P. L.
Stathis, A.
Carlo-Stella, C.
Citations
Altmetric:
Abstract
Description
Date
2021
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Alderuccio JP, Ai WZ, Radford J, Solh M, Ardeshna KM, Lunning MA, et al. Clinical Characteristics and Responses of Patients with Relapsed or Refractory High-Grade B-Cell Lymphoma Treated with Loncastuximab Tesirine in the Lotis-2 Clinical Trial. Blood. 2021 Nov;138. PubMed PMID: WOS:000736413906140.